Correlation Between Pfizer and Invesco SP
Can any of the company-specific risk be diversified away by investing in both Pfizer and Invesco SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Invesco SP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Invesco SP SmallCap, you can compare the effects of market volatilities on Pfizer and Invesco SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Invesco SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Invesco SP.
Diversification Opportunities for Pfizer and Invesco SP
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Pfizer and Invesco is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Invesco SP SmallCap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco SP SmallCap and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Invesco SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco SP SmallCap has no effect on the direction of Pfizer i.e., Pfizer and Invesco SP go up and down completely randomly.
Pair Corralation between Pfizer and Invesco SP
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Invesco SP. In addition to that, Pfizer is 1.13 times more volatile than Invesco SP SmallCap. It trades about -0.08 of its total potential returns per unit of risk. Invesco SP SmallCap is currently generating about 0.07 per unit of volatility. If you would invest 4,653 in Invesco SP SmallCap on September 12, 2024 and sell it today you would earn a total of 2,504 from holding Invesco SP SmallCap or generate 53.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Invesco SP SmallCap
Performance |
Timeline |
Pfizer Inc |
Invesco SP SmallCap |
Pfizer and Invesco SP Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Invesco SP
The main advantage of trading using opposite Pfizer and Invesco SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Invesco SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco SP will offset losses from the drop in Invesco SP's long position.Pfizer vs. Victory Integrity Smallmid Cap | Pfizer vs. Hilton Worldwide Holdings | Pfizer vs. NVIDIA | Pfizer vs. JPMorgan Chase Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |